UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.363

Sortiert nach

Functional assessment of CYP3A4 and CYP2C19 genetic polymorphisms on the metabolism of clothianidin invitro

Chemico-biological interactions, 2024-08, Vol.399, p.111154, Article 111154

2024

Link zum Volltext

Verfügbarkeit prüfen

Effects of CYP3A4 genetic polymorphisms on the pharmacokinetics and efficacy of perampanel in Chinese pediatric patients with epilepsy

Seizure (London, England), 2024-08, Vol.120, p.142-149

2024

Link zum Volltext

Verfügbarkeit prüfen

Innovative C2-symmetric testosterone and androstenedione dimers: Design, synthesis, biological evaluation on prostate cancer cell lines and binding study to recombinant CYP3A4

European journal of medicinal chemistry, 2021-08, Vol.220, p.113496-113496, Article 113496

2021

Link zum Volltext

Verfügbarkeit prüfen

Iminium ion metabolites are formed from nintedanib by human CYP3A4

Drug metabolism and pharmacokinetics, 2024-08, Vol.57, p.101025, Article 101025

2024

Link zum Volltext

Verfügbarkeit prüfen

Characterization of plasma vonoprazan and CYP3A activity using its endogenous marker and genetic variants in patients with digestive system disorders

Drug metabolism and pharmacokinetics, 2024-07, p.101027, Article 101027

2024

Link zum Volltext

Verfügbarkeit prüfen

CYP2C9, CYP3A and CYP2C19 metabolize Δ9-tetrahydrocannabinol to multiple metabolites but metabolism is affected by human liver fatty acid binding protein (FABP1)

Biochemical pharmacology, 2024-04, p.116191-116191, Article 116191

2024

Link zum Volltext

Verfügbarkeit prüfen

Association between CYP3A4 gene polymorphisms and clopidogrel response in patients with cardio-cerebrovascular diseases: a systematic review and Meta-analysis

Journal of Chinese pharmaceutical sciences, 2021-09, Vol.29 (9), p.762-772

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of CYP3A4 and CYP2C8 Polymorphism on Amiodarone Responses: Review Article

Pharmacognosy journal, 2023-06, Vol.15 (3), p.467-470

Sutrisna, Em

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" Problem

Frontiers in genetics, 2013, Vol.4, p.12

2013

Link zum Volltext

Verfügbarkeit prüfen

The role of cytochrome b 5 structural domains in interaction with cytochromes P450

Biochemistry (Moscow), 2014-05, Vol.79 (5), p.406-416

2014

Link zum Volltext

Verfügbarkeit prüfen

Genetic variation present in the CYP3A4 gene in Ni-Vanuatu and Kenyan populations in malaria endemicity

Drug metabolism and pharmacokinetics, 2024-07, p.101029, Article 101029

2024

Link zum Volltext

Verfügbarkeit prüfen

The impact of CYP3A5 3 polymorphism on sirolimus pharmacokinetics: insights from predictions with a physiologically‐based pharmacokinetic model

British journal of clinical pharmacology, 2015-12, Vol.80 (6), p.1438-1446

2015

Link zum Volltext

Verfügbarkeit prüfen

CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation?

Frontiers in genetics, 2021-07, Vol.12, p.711943-711943

2021

Link zum Volltext

Verfügbarkeit prüfen

PRMT1 Contributes to HNF1A‐AS1‐mediated Regulation Network of CYP3A4 in Huh7 Cells

The FASEB journal, 2021-05, Vol.35 (S1), p.n/a, Article fasebj.2021.35.S1.03387

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of CYP3A4 genetic polymorphisms on pharmacokinetics of tinidazole

Journal of Chinese pharmaceutical sciences, 2020-04, Vol.29 (4), p.272-279

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study)

European journal of cancer (1990), 2023-11, Vol.194, p.113346-113346, Article 113346

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Dexamethasone when Administered with Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting and Differences in Dose-Dependent Antiemetic Effects

Asian Pacific journal of cancer prevention : APJCP, 2021-03, Vol.22 (3), p.871-877

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of CYP3A41B, CYP3A422 and CYP3A53 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia

Farmaciâ i Farmakologiâ (Pâtigorsk), 2024-05, Vol.12 (1), p.32-48

2024

Link zum Volltext

Verfügbarkeit prüfen

Functional evaluation of CYP2C19 and CYP3A4 gene polymorphism on ibuprofen metabolism

Toxicology and applied pharmacology, 2023-09, Vol.475, p.116653-116653, Article 116653

2023

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model

Journal of clinical pharmacology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Stress as a Potential Regulatory Factor in the Outcome of Pharmacotherapy

Frontiers in neuroscience, 2022-03, Vol.16, p.737716-737716

2022

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and anticancer properties of a hybrid molecule with the testosterone and estradiol head-groups

Steroids, 2024-09, Vol.209, p.109469, Article 109469

2024

Link zum Volltext

Verfügbarkeit prüfen

Molecular dynamics simulation and in vitro evaluation of herb–drug interactions involving dietary polyphenols and CDK inhibitors in breast cancer chemotherapy

Phytotherapy research, 2022-10, Vol.36 (10), p.3988-4001

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical poisoning events involving yunaconitine may be highly correlated with metabolism-based interactions: A critical role of CYP3A4

Food and chemical toxicology, 2023-09, Vol.179, p.113989-113989, Article 113989

2023

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D pathway gene polymorphisms influenced vitamin D level among pregnant women

Clinical nutrition (Edinburgh, Scotland), 2018-12, Vol.37 (6), p.2230-2237

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.363

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.188)
Mit Volltextzugriff
(2.093)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.994)
Life Sciences & Biomedicine
(1.957)
Cyp3a4
(1.946)
Humans
(1.508)
Pharmacology & Pharmacy
(1.349)
Male
(638)
Biological And Medical Sciences
(518)
Female
(490)
Medical Sciences
(489)
Cytochrome P-450 Cyp3a - Metabolism
(481)
Drug Interactions
(477)
Adult
(444)
Cytochrome P-450 Cyp3a
(442)
Pharmacokinetics
(409)
Pharmacology. Drug Treatments
(409)
Cytochrome P450
(365)
Metabolism
(354)
Cytochrome P-450 Enzyme System - Metabolism
(352)
Middle Aged
(343)
Animals
(334)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(20)
... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Functional assessment of CYP3A4 and CYP2C19 genetic polymorphisms on the metabolism of clothianidin invitro

Effects of CYP3A4 genetic polymorphisms on the pharmacokinetics and efficacy of perampanel in Chinese pediatric patients with epilepsy

Innovative C2-symmetric testosterone and androstenedione dimers: Design, synthesis, biological evaluation on prostate cancer cell lines and binding study to recombinant CYP3A4

Iminium ion metabolites are formed from nintedanib by human CYP3A4

Characterization of plasma vonoprazan and CYP3A activity using its endogenous marker and genetic variants in patients with digestive system disorders

CYP2C9, CYP3A and CYP2C19 metabolize Δ9-tetrahydrocannabinol to multiple metabolites but metabolism is affected by human liver fatty acid binding protein (FABP1)

Association between CYP3A4 gene polymorphisms and clopidogrel response in patients with cardio-cerebrovascular diseases: a systematic review and Meta-analysis

The Role of CYP3A4 and CYP2C8 Polymorphism on Amiodarone Responses: Review Article

Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" Problem

The role of cytochrome b 5 structural domains in interaction with cytochromes P450

Genetic variation present in the CYP3A4 gene in Ni-Vanuatu and Kenyan populations in malaria endemicity

The impact of CYP3A5 3 polymorphism on sirolimus pharmacokinetics: insights from predictions with a physiologically‐based pharmacokinetic model

CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation?

PRMT1 Contributes to HNF1A‐AS1‐mediated Regulation Network of CYP3A4 in Huh7 Cells

Effect of CYP3A4 genetic polymorphisms on pharmacokinetics of tinidazole

Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study)

Pharmacokinetics of Dexamethasone when Administered with Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting and Differences in Dose-Dependent Antiemetic Effects

Association of CYP3A41B, CYP3A422 and CYP3A53 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia

Functional evaluation of CYP2C19 and CYP3A4 gene polymorphism on ibuprofen metabolism

Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model

Stress as a Potential Regulatory Factor in the Outcome of Pharmacotherapy

Synthesis and anticancer properties of a hybrid molecule with the testosterone and estradiol head-groups

Molecular dynamics simulation and in vitro evaluation of herb–drug interactions involving dietary polyphenols and CDK inhibitors in breast cancer chemotherapy

Clinical poisoning events involving yunaconitine may be highly correlated with metabolism-based interactions: A critical role of CYP3A4

Vitamin D pathway gene polymorphisms influenced vitamin D level among pregnant women

Suchergebnisse filtern